Abstract
Triamcinolone acetonide suspension is a long acting corticosteroid product for intra-lesional injection of hemangiomas in our series. There were very few cases reported about triamcinolone induced anaphylactic reaction previously. From April 2001 to April 2005, there are 277 hemangioma patients who received intra-lesional triamcinolone injection in our series. 7 of them suffered from anaphylactic reaction immediately after the treatment. They were recovered smoothly after resuscitation with intramuscular epinephrine injection and oxygen supply. We presented these seven patients about their signs and symptoms of anaphylaxis, treatment protocols, and their following alternative treatment of hemangiomas, and we also reviewed the proposed mechanisms of corticosteroid-associated hypersensitivity reactions in this study.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
